Creating a free account will enable you to subscribe to our daily and weekly email newsletters, as well as customize your reading experience to show only the categories most relevant to you.
Signing up only take a few minutes, so why not give it a try and see what you've been missing out on.
The Patient-Centered Outcomes Research Institute (PCORI) has approved a total of $97.3 million in new funding for 53 comparative effectiveness research (CER) studies designed to answer questions of most importance to patients and those who care for them. It has also approved $93.5 million to build and expand the individual research data networks that will form PCORnet, an ambitious new national patient-centered clinical research network to facilitate CER.
The awards, approved during a special PCORI Board of Governors webinar/teleconference, will support research aimed at providing patients, their families, and other healthcare stakeholders more information about the effectiveness of various healthcare options so they can make better-informed decisions about their care.
Studies approved include efforts to improve care for heart disease, cancer, obesity, chronic pain, diabetes, respiratory disorders, and mental health disorders among other conditions. Several projects will explore ways to support patient and family caregiver decision-making, reduce health disparities, and improve healthcare delivery systems.
Eight of the awards for CER studies will fund studies of multipronged strategies to reduce persistent disparities in uncontrolled asthma among African Americans and Hispanics/Latinos, the population groups at greatest risk for developing this common respiratory disease. These awards were made through PCORI's first call for applications on a specific high-priority research topic. PCORI specifically called for proposals on this topic because not all treatment options work well for all populations and asthma has many triggers including environmental and social factors not typically addressed by medical providers. The eight projects were chosen from a pool of 74 applications to this targeted announcement.
PCORI selected the other 45 CER studies for funding from a total of 461 submissions to broad funding announcements issued under its five National Priorities for Research in August 2013. These and the asthma awards will go to 65 institutions in 23 states as well as Washington, D.C., and Quebec.
"We are very pleased to add this latest round of projects to our growing portfolio of patient-centered comparative effectiveness research, which will contribute much-needed insights about the benefits and risks of a range of medical interventions and approaches to healthcare delivery," said PCORI Executive Director Joe Selby, MD, MPH. "Each project will engage patients and other stakeholders in meaningful ways with researchers to tackle critical health problems. We look forward to following and learning from the studies' progress."
The projects approved today were selected through a competitive review process in which patients, caregivers, and other stakeholders joined scientists in evaluating proposals on the basis of scientific merit, how well they engage patients and other stakeholders, and their methodological rigor among other criteria. All awards are approved pending completion of a business and programmatic review by PCORI staff and completion of a formal award contract.
Article adapted by Medical News Today from original press release. Click 'references' tab above for source.
Visit our Public Health category page for the latest news on this subject.
Please use one of the following formats to cite this article in your essay, paper or report:
PCORI. "PCORI approves $191 million to support patient-centered comparative effectiveness research." Medical News Today. MediLexicon, Intl., 19 Dec. 2013. Web.
9 Mar. 2014. <http://www.medicalnewstoday.com/releases/270377>
PCORI. (2013, December 19). "PCORI approves $191 million to support patient-centered comparative effectiveness research." Medical News Today. Retrieved from
Please note: If no author information is provided, the source is cited instead.
If you write about specific medications, operations, or procedures please do not name healthcare professionals by name.
For any corrections of factual information, or to contact our editorial team, please use our feedback form. Please send any medical news or health news press releases to:
Note: Any medical information published on this website is not intended as a substitute for informed medical advice and you should not take any action before consulting with a health care professional. For more information, please read our terms and conditions.
This page was printed from: http://www.medicalnewstoday.com/releases/270377.php
Visit www.medicalnewstoday.com for medical news and health news headlines posted throughout the day, every day.
© 2004-2014 All rights reserved. MNT (logo) is the registered trade mark of MediLexicon International Limited.